Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
ProPhase Labs	PRPH	15. nov 2024	0.75	-0.19
ProQR Therapeutics	PRQR	15. nov 2024	3.82	-3.29
PROS	PRO	15. nov 2024	22.74	-2.61
ProShares Bitcoin Strategy ETF	BITO	15. nov 2024	24.66	+4.58
Proshares Ultra FTSE Europe	UPV	15. nov 2024	56.66	-0.58
ProShares UltraShort Bloomberg Natural Gas	KOLD	15. nov 2024	71.96	-3.38
Proshares Ultrashort FTSE Europe	EPV	15. nov 2024	40.91	+0.52
Prospect Capital	PSEC	15. nov 2024	4.42	+0.91
Prospect Capital A Pref	PSEC-A	15. nov 2024	18.60	-1.17
Prosperity Bancshares	PB	15. nov 2024	82.50	+0.50
Protagenic Therapeutics	PTIX	15. nov 2024	0.62	-10.52
Protagonist Therapeutics	PTGX	15. nov 2024	41.11	+0.17
Protalix Bio Therapeutics	PLX	15. nov 2024	1.40	-0.71
Protara Therapeutics	TARA	15. nov 2024	2.47	-4.26
Prothena	PRTA	15. nov 2024	14.01	-12.98
Proto Labs	PRLB	15. nov 2024	37.47	-1.47
Provident Bancorp	PVBC	15. nov 2024	11.00	+0.82
Provident Financial	PROV	15. nov 2024	15.90	+0.32
Provident Financial Services	PFS	15. nov 2024	21.40	-0.09
Prudential ADR	PUK	15. nov 2024	16.13	+1.77
Prudential Financial	PRU	15. nov 2024	127.41	+1.32
Ps International Group	PSIG	15. nov 2024	0.53	-1.87
PSQ Holdings	PSQH	15. nov 2024	2.32	-5.69
Psychemedics	PMD	15. nov 2024	2.34	-0.64
Psyence Biomedical	PBM	15. nov 2024	0.05	-6.30
PT Telkom Indonesia (Persero) Tbk ADR	TLK	15. nov 2024	15.83	+0.13
PTC	PTC	15. nov 2024	190.01	-0.58
PTC Therapeutics	PTCT	15. nov 2024	39.23	-7.43
PTL LTD - Ordinary Shares	PTLE	15. nov 2024	3.25	0.00
Public Service Enterprise	PEG	15. nov 2024	88.99	+2.29

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.